X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with Fulford India - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs FULFORD INDIA - Comparison Results

FULFORD INDIA 
   Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB FULFORD INDIA UNICHEM LAB/
FULFORD INDIA
 
P/E (TTM) x 32.8 398.8 8.2% View Chart
P/BV x 3.5 6.2 55.6% View Chart
Dividend Yield % 0.5 0.1 649.3%  

Financials

 UNICHEM LAB   FULFORD INDIA
EQUITY SHARE DATA
    UNICHEM LAB
Mar-16
FULFORD INDIA
Mar-14
UNICHEM LAB/
FULFORD INDIA
5-Yr Chart
Click to enlarge
High Rs334942 35.5%   
Low Rs174450 38.7%   
Sales per share (Unadj.) Rs146.9691.4 21.2%  
Earnings per share (Unadj.) Rs11.911.5 103.8%  
Cash flow per share (Unadj.) Rs16.215.4 105.4%  
Dividends per share (Unadj.) Rs2.002.00 100.0%  
Dividend yield (eoy) %0.80.3 274.0%  
Book value per share (Unadj.) Rs105.1380.0 27.7%  
Shares outstanding (eoy) m90.843.90 2,329.2%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x1.71.0 171.7%   
Avg P/E ratio x21.460.7 35.2%  
P/CF ratio (eoy) x15.745.3 34.6%  
Price / Book Value ratio x2.41.8 131.9%  
Dividend payout %16.817.4 96.4%   
Avg Mkt Cap Rs m23,0732,714 850.0%   
No. of employees `0005.70.4 1,277.7%   
Total wages/salary Rs m2,558505 506.5%   
Avg. sales/employee Rs Th2,352.56,073.0 38.7%   
Avg. wages/employee Rs Th450.91,137.4 39.6%   
Avg. net profit/employee Rs Th190.4100.7 189.2%   
INCOME DATA
Net Sales Rs m13,3462,696 494.9%  
Other income Rs m192125 153.0%   
Total revenues Rs m13,5382,822 479.7%   
Gross profit Rs m1,639-46 -3,532.3%  
Depreciation Rs m39015 2,565.8%   
Interest Rs m2910 303.2%   
Profit before tax Rs m1,41254 2,600.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m-40-   
Extraordinary Inc (Exp) Rs m-350-   
Tax Rs m29310 3,049.0%   
Profit after tax Rs m1,08045 2,417.0%  
Gross profit margin %12.3-1.7 -713.7%  
Effective tax rate %20.717.7 117.2%   
Net profit margin %8.11.7 488.3%  
BALANCE SHEET DATA
Current assets Rs m5,9791,738 344.0%   
Current liabilities Rs m2,432545 446.5%   
Net working cap to sales %26.644.3 60.0%  
Current ratio x2.53.2 77.0%  
Inventory Days Days6348 130.1%  
Debtors Days Days604 1,402.6%  
Net fixed assets Rs m6,40312 53,803.4%   
Share capital Rs m18239 465.9%   
"Free" reserves Rs m9,2931,443 644.0%   
Net worth Rs m9,5481,482 644.3%   
Long term debt Rs m2300-   
Total assets Rs m12,8432,077 618.4%  
Interest coverage x50.06.7 745.0%   
Debt to equity ratio x00-  
Sales to assets ratio x1.01.3 80.0%   
Return on assets %8.62.6 330.9%  
Return on equity %11.33.0 375.1%  
Return on capital %14.34.3 333.0%  
Exports to sales %29.20-   
Imports to sales %6.324.5 25.9%   
Exports (fob) Rs m3,900NA-   
Imports (cif) Rs m847659 128.4%   
Fx inflow Rs m4,35617 25,327.9%   
Fx outflow Rs m1,162673 172.7%   
Net fx Rs m3,194-656 -486.9%   
CASH FLOW
From Operations Rs m1,11990 1,243.4%  
From Investments Rs m-853105 -815.8%  
From Financial Activity Rs m-334-14 2,370.2%  
Net Cashflow Rs m-68181 -37.8%  

Share Holding

Indian Promoters % 50.1 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 15.1 3.8 397.4%  
FIIs % 3.0 0.1 3,000.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 21.2 149.5%  
Shareholders   20,176 4,783 421.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   MERCK LTD  CIPLA  TORRENT PHARMA  SUVEN LIFE  STERLING BIOTECH  

Compare UNICHEM LAB With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Of Global Markets Hitting Record Highs and Top Stocks in Action During the Week(RoundUp)

Global stock markets ended the week on a positive note. Benchmark indices in US grew by 1% during the week. The Down Jones Industrial Average topped the 26,000.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Jan 19, 2018 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 8-QTR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS